Prefrontal cortex (PFC) is an associative center of the brain that integrates local and long-range inputs from cortical and subcortical structures to support working memory and complex decision-making behaviors. Layer 5 pyramidal cells in PFC are themselves associative centers, as they have dendrites that span all cortical layers and can integrate inputs from different input basal and apical streams. In mouse PFC, layer 5 pyramidal cells can be classified based on their dopamine receptor expression pattern. Recent work has identified a novel class of D3 dopamine receptor (D3R)-expressing pyramidal cell that is distinct from the D1 and D2 dopamine receptor-expressing pyramidal cell classes. D3R-expressing pyramidal neurons have been characterized in terms of their morphologies, projection patterns, and intrinsic properties, but this opens up more questions: (1) how do D3R-binding ligands, such as second generation antipsychotic drugs, change the activity of these cells, (2) how are inputs to PFC layer 5 processed across D1, D2, and D3R-expressing neurons, and (3) how do these cells contribute to decision-making behavior?
Here, I use whole-cell patch-clamp recordings, two-photon laser-scanning microscopy, and calcium imaging to show that some second generation antipsychotic drugs, thought of antagonists for G-protein signaling at D3R, can also act as agonists for arrestin signaling at D3R. Arrestin recruitment to D3R can, acutely, result in modulation of calcium at the axon initial segment and, chronically, lead to D3R internalization and degradation. I go on to show that D3R-expressing pyramidal cells, more so than their D1R- and D2R-expressing counterparts, in their apical dendrites exhibit supralinear calcium transients evoked by a burst of backpropagating action potentials. A lack of hyperpolarization-activated cyclic nucleotide-gated channels appears to contribute to this difference across cell classes. These data suggest that there are several features of D3R-expressing pyramidal neurons that differentiate them from other PFC layer 5 pyramidal cells and suggest that information flow through PFC layer 5 is not equivalently processed. Finally, while not a direct test of D3R function, I use a complex decision-making behavior to show that animals with Scn2a haploinsufficiency, which have reduced dendritic excitability in PFC layer 5 pyramidal cells, exhibit no behavioral differences across several behavioral metrics. Taken together, these data further our understanding of dopamine receptors, second generation antipsychotic drug action, and ion channels in layer 5 pyramidal neuron subtypes and in prefrontal cortical processing.